BCL2A1 and cancer: BFL-1 expression has been shown to be relatively high in melanoma23–25 and implicated in melanoma cell survival17,19,23 as Bfl-1 knockdown enhances sensitivity to ABT-737 and other anti-cancer agents, though the effect is cell line dependent and in some cases minor17,19,23,24.